Menu

Turning Point Therapeutics, Inc. TPTX

Full chart Compare
Set alert

Price alert · TPTX

All alert types
75.49 +75.49

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $1.45MExpenses → Selling, General & Admin: $75.85MExpenses → Research & Development: $192.98MGross Profit → Expenses: $30.83MRevenue → Gross Profit: $30.83MNet Loss → Expenses: $236.55MOther Income$1.45MGross Profit$30.83MNet Loss$236.55MExpenses$268.83MSelling, General & Admin$75.85MResearch & Development$192.98MRevenue$30.83M

Latest period ending Dec 31, 2021 · select a line to chart its full history

Annual income statement

TPTX annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
30.83M25.00M000
30.83M25.00M000
30.83M25.00M000
268.83M186.84M77.72M25.64M16.73M
192.98M113.41M57.94M21.06M15.24M
75.85M73.42M19.78M4.58M1.49M
-238.00M-161.84M-77.72M-25.64M-16.73M
-236.55M-157.29M-72.13M-24.79M-16.59M
-236.55M-157.29M-72.13M-24.79M-16.59M
-236.55M-157.29M-72.13M-24.79M-16.59M
-236.55M-157.29M-72.13M-24.79M-16.59M
-4.80-3.85-2.99-7.31-4.97
-4.80-3.85-2.99-7.31-4.97
-4.80-3.85-2.99-7.31-4.97
-236.55M-157.29M-72.13M-24.79M-16.59M
-236.55M-157.29M-72.13M-24.79M-16.59M
49.26M40.84M24.12M3.39M3.34M
49.26M40.84M24.12M3.39M3.34M